Marius Pharmaceuticals Announces Final Published Phase 3 Data from MRS-TU-2019EXT Studying the Safety and Efficacy of FDA-Approved KYZATREX® (testosterone undecanoate) CII Capsules

/PRNewswire/ -- Marius Pharmaceuticals, a pharmaceutical company focused on developing innovative therapies for testosterone deficiency, today announced...

Related Keywords

United States ,American ,Amyb Odonnell ,Jamess Bernstein ,Andreb Araujo ,Thomasg Travison ,Shalin Shah ,Johnb Mckinlay ,Varant Kupelian ,J Clin Endocrinol ,Marius Pharmaceuticals ,Data Published ,Therapeutic Advances ,Helping Restore Testosterone Levels ,Free Testosterone ,Oral Testosterone ,Marius Pharmaceutical ,Important Safety Information ,Boxed Warning ,Safety Information ,Full Prescribing Information ,Medication Guide ,Population Level Decline ,Serum Testosterone Levels ,American Men ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Pharmaceuticals ,Clinical Trials Amp Medical Discoveries ,